Eastern Institute of Technology professor recognized for advancing PFAS and emerging contaminant analysis
Agilent Technologies Inc. (NYSE: A) will release financial results for the third quarter of fiscal year 2026 after the stock market closes on Wednesday, Aug. 26. The company will host a conference call...
Agilent Technologies is poised to release its third-quarter results soon, and analysts are projecting a single-digit earnings rise.
1 Healthcare Stock to Research Further and 2 We Avoid
Approval expands PD-L1 testing to support treatment decisions with KEYTRUDA ® (pembrolizumab)
1 of Wall Street’s Favorite Stocks on Our Buy List and 2 We Brush Off
Test enables identification of patients whose tumors express PD-L1 and who may be eligible for treatment with OPDIVO® (nivolumab) or OPDIVO QVANTIG®
Agilent (A): Buy, Sell, or Hold Post Q1 Earnings?
Agilent Technologies Inc. (NYSE: A) today announced the latest expansion of its Altura HPLC column portfolio with the introduction of Altura size exclusion chromatography (SEC) and Altura PLRP-S...
Simplifying label-free imaging analysis for more confident real-time cell analysis